Case Report

Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Volume: 2 Number: 2 August 1, 2022
  • Zehra Pınar Koç *
  • Pınar Pelin Özcan
  • Nurdan Oruçoğlu
  • Hamide Sayar

Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Abstract

Aim: The retrospective evaluation of abdominal vasculitis detected by FDG PET/CT examinations. Materials and Methods: Seven patients (3 Female, 4 Male, 26-72 years old) were subjects of this study. The images of the patients as well as clinic and pathologic features were analyzed retrospectively. Results: The determination of the abdominal vasculitis is possible as a primary diagnosis or incidentally during an investigation of a known another disease (malignancy). Conclusion: This case series demonstrates the significance of this clinical entity as well as the associated malignancy with this disease by FDG PET/CT.

Keywords

References

  1. 1. Galli, E., Muratore, F., Mancuso, P., Boiardi, L., Marvisi, C., Besutti, G., Spaggiari, L., Casali, M., Versari, A., Giorgi Rossi, P., & Salvarani, C. (2022). The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Rheumatology (Oxford, England), keac125. Advance online publication. https://doi.org/10.1093/rheumatology/keac125
  2. 2. Chen, Z., Zhao, Y., Wang, Q., Li, Y., Li, H., & Zhou, Y. (2022). Imaging features of 18F-FDG PET/CT in different types of systemic vasculitis. Clinical rheumatology, 41(5), 1499–1509. https://doi.org/10.1007/s10067-021-06039-1
  3. 3. Bonnefoy PB, Goutte J, Jacquet-Francillon N, Habouzit V, Prevot N. Usual and Rare Abdominal Location of Giant Cell Arteritis Diagnosed and Follow-up With 18F-FDG PET/CT. Clin Nucl Med. 2021 Apr 1;46(4):e218-e220
  4. 4. Wu, S., Pang, Y., Zhao, L., Zhao, L., & Chen, H. (2021). 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for the Evaluation of Disease Activity in Takayasu Arteritis. Clinical nuclear medicine, 46(10), 847–849. https://doi.org/10.1097/RLU.0000000000003692
  5. 5. Espitia, O., Blonz, G., Urbanski, G., Landron, C., Connault, J., Lavigne, C., Roblot, P., Maillot, F., Audemard-Verger, A., Artifoni, M., Durant, C., Guyomarch, B., Hamidou, M., Magnant, J., Agard, C., & French Study Group for Large Vessel Vasculitis (GEFA) (2021). Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event. Arthritis research & therapy, 23(1), 14. https://doi.org/10.1186/s13075-020-02396-5
  6. 6. Mestre-Torres, J., Martínez-Valle, F., Gabaldón, A., Simó-Perdigó, M., Salcedo-Allende, M. T., Navales-Mateu, I., & Solans-Laqué, R. (2022). Are Temporal Artery Biopsy Findings Related to PET/CT Findings in Giant Cell Arteritis?. Clinical nuclear medicine, 47(5), 387–393. https://doi.org/10.1097/RLU.0000000000004097
  7. 7. Galli, E., Muratore, F., Mancuso, P., Boiardi, L., Marvisi, C., Besutti, G., Spaggiari, L., Casali, M., Versari, A., Giorgi Rossi, P., & Salvarani, C. (2022). The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Rheumatology (Oxford, England), keac125. Advance online publication. https://doi.org/10.1093/rheumatology/keac125
  8. 8. Duff L, Scarsbrook AF, Mackie SL, Frood R, Bailey M, Morgan AW, Tsoumpas C. A methodological framework for AI-assisted diagnosis of active aortitis using radiomic analysis of FDG PET-CT images: Initial analysis. J Nucl Cardiol. 2022 Mar 23. doi: 10.1007/s12350-022-02927-4

Details

Primary Language

English

Subjects

Oncology and Carcinogenesis

Journal Section

Case Report

Authors

Zehra Pınar Koç * This is me
0000-0002-3274-5790
Türkiye

Pınar Pelin Özcan This is me
0000-0003-0147-2678
Türkiye

Nurdan Oruçoğlu This is me
0000-0002-8613-5373
Türkiye

Publication Date

August 1, 2022

Submission Date

July 15, 2022

Acceptance Date

July 30, 2022

Published in Issue

Year 2022 Volume: 2 Number: 2

APA
Koç, Z. P., Özcan, P. P., Oruçoğlu, N., & Sayar, H. (2022). Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging, 2(2), 1-5. https://izlik.org/JA65MD48XC
AMA
1.Koç ZP, Özcan PP, Oruçoğlu N, Sayar H. Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2022;2(2):1-5. https://izlik.org/JA65MD48XC
Chicago
Koç, Zehra Pınar, Pınar Pelin Özcan, Nurdan Oruçoğlu, and Hamide Sayar. 2022. “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography Computed Tomography”. Molecular Oncologic Imaging 2 (2): 1-5. https://izlik.org/JA65MD48XC.
EndNote
Koç ZP, Özcan PP, Oruçoğlu N, Sayar H (August 1, 2022) Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging 2 2 1–5.
IEEE
[1]Z. P. Koç, P. P. Özcan, N. Oruçoğlu, and H. Sayar, “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”, Molecular Oncologic Imaging, vol. 2, no. 2, pp. 1–5, Aug. 2022, [Online]. Available: https://izlik.org/JA65MD48XC
ISNAD
Koç, Zehra Pınar - Özcan, Pınar Pelin - Oruçoğlu, Nurdan - Sayar, Hamide. “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography Computed Tomography”. Molecular Oncologic Imaging 2/2 (August 1, 2022): 1-5. https://izlik.org/JA65MD48XC.
JAMA
1.Koç ZP, Özcan PP, Oruçoğlu N, Sayar H. Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2022;2:1–5.
MLA
Koç, Zehra Pınar, et al. “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography Computed Tomography”. Molecular Oncologic Imaging, vol. 2, no. 2, Aug. 2022, pp. 1-5, https://izlik.org/JA65MD48XC.
Vancouver
1.Zehra Pınar Koç, Pınar Pelin Özcan, Nurdan Oruçoğlu, Hamide Sayar. Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging [Internet]. 2022 Aug. 1;2(2):1-5. Available from: https://izlik.org/JA65MD48XC